Evidence map›Paper›PMID 37851073›Full record

ArticleAnnals of hematology2024

Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma.

James A Davis, Aswani Thurlapati, Erin Weeda, Kelly J Gaffney, Deidra Smith, Andy Maldonado, Katelynn Granger, Kristy E Martin, Yolanda M Williams, Taylor Herrington and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

James A DavisDivision of Malignant Hematology and Bone Marrow Transplant, Department of Pharmacy, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC, 29425, USA. Davisjaa@musc.edu.ORCID http://orcid.org/0000-0001-7978-1652
Aswani ThurlapatiDepartment of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Erin WeedaMedical University of South Carolina College of Pharmacy, Charleston, SC, USA.
Kelly J GaffneyDivision of Malignant Hematology and Bone Marrow Transplant, Department of Pharmacy, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC, 29425, USA.
Deidra SmithDivision of Malignant Hematology and Bone Marrow Transplant, Department of Pharmacy, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC, 29425, USA.
Andy MaldonadoDivision of Malignant Hematology and Bone Marrow Transplant, Department of Pharmacy, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC, 29425, USA.
Katelynn GrangerDivision of Malignant Hematology and Bone Marrow Transplant, Department of Pharmacy, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC, 29425, USA.
Kristy E MartinDepartment of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Yolanda M WilliamsDepartment of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Taylor HerringtonMedical University of South Carolina College of Pharmacy, Charleston, SC, USA.
Arash VelayatiDepartment of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Jonathan K BakosDepartment of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Kimberly GreenDepartment of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Hamza HashmiDepartment of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-Hispanic Black patients are disproportionally affected by multiple myeloma (MM) and whether efficacy outcomes after autologous stem cell transplant (ASCT) differ by race and ethnicity remains an area of active investigation. This study included 449 patients enriched with a large proportion of non-Hispanic Black patients and sought to highlight the impact of race and ethnicity on outcomes after HDT-ASCT for patients with newly diagnosed MM. We found induction chemotherapy followed by high-dose therapy-ASCT and maintenance chemotherapy is associated with long-term PFS and OS, regardless of race or ethnicity.

Indexed as

Hematopoietic Stem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalEthnicityHumansRetrospective StudiesStem Cell TransplantationTransplantation, AutologousDisparitiesEthnicityMyelomaRaceTransplant

Identifiers

PMID37851073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.